A Novel Variant in Dopamine Receptor Type 2 Gene is Associated with Schizophrenia

Being the primary target of antipsychotic therapy, dopamine receptor type 2 (DRD2) remains a point of interest in schizophrenia pathology. Polymorphisms in DRD2 have been shown to alter patients’ response to antipsychotics. DRD2 SNP rs6275 (C>T) have found to be associated with schizophrenia in d...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Archives of medical research 2021-04, Vol.52 (3), p.348-353
Hauptverfasser:	Hanif, Farina, Amir, Qurat-ul-Ain, Washdev, Washdev, Bilwani, Fareena, Simjee, Shabana Usman, Haque, Zeba
Format:	Artikel
Sprache:	eng
Schlagworte:	Dopamine DRD2 Polymorphism Schizophrenia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!